🔴 Iovance Biotherapeutics is trading 4.40% down

Iovance Biotherapeutics is trading 4.40% down at $13.47 on October 26, 2026; no clear downside catalyst has been confirmed.

• Shares declined despite broad U.S. indexes trading higher, so the market trend does not explain the move.
• At ESMO on October 26, the company presented early lifileucel sarcoma data, including a 50% response rate among the first eight evaluable patients.